Drug
Avi 4065
Avi 4065: highest development phase Phase 1/2, developed by Sarepta Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| AVI-4065 Injection NCT00229749 | Phase 1/2 | Hepatitis C |
Latest
No recent events.
Follow Avi 4065 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.